Immunome, Inc.IMNMNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P37
Within normal range
vs 3Y Ago
-2.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -24.81% |
| Q3 2025 | 17.25% |
| Q2 2025 | 11.31% |
| Q1 2025 | -30.59% |
| Q4 2024 | -21.65% |
| Q3 2024 | -38.71% |
| Q2 2024 | -93.05% |
| Q1 2024 | 25.12% |
| Q4 2023 | -105.87% |
| Q3 2023 | -43.97% |
| Q2 2023 | -124.96% |
| Q1 2023 | 456.28% |
| Q4 2022 | 10.78% |
| Q3 2022 | 8.01% |
| Q2 2022 | -28.96% |
| Q1 2022 | 6.41% |
| Q4 2021 | -63.49% |
| Q3 2021 | -11.26% |
| Q2 2021 | -5.13% |
| Q1 2021 | 41.62% |
| Q4 2020 | -130.32% |
| Q3 2020 | -44.05% |
| Q2 2020 | 13.12% |
| Q1 2020 | 19.92% |
| Q4 2019 | -6.44% |
| Q3 2019 | -5.76% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |